RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 82.05
+0.15 (0.18%)
At close: Feb 23, 2026
RemeGen Market Cap
RemeGen has a market cap or net worth of 57.22 billion as of February 23, 2026. Its market cap has increased by 338.40% in one year.
Market Cap
57.22B
Enterprise Value
58.32B
Revenue
2.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
82.05
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 57.22B, an increase of 71.37%. That is a compound annual growth rate of 10.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 57.20B | 26.55% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 118.88B |
| Akeso | 100.50B |
| Sichuan Kelun-Biotech Biopharmaceutical | 97.15B |
| 3SBio | 59.69B |
| Shanghai Henlius Biotech | 39.27B |
| Shanghai Junshi Biosciences | 35.38B |
| Biocytogen Pharmaceuticals (Beijing) | 34.58B |
| Duality Biotherapeutics | 31.46B |